Below are the financial statements of Bayer, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of EUR | 2024 | 2023 |
|---|---|---|
| Net sales | 46,606a | 47,637a |
| Cost of goods sold | -21,270a | -19,749a |
| Gross profit | 25,336a | 27,888a |
| Selling expenses | -13,364a | -12,482a |
| Research and development expenses | -6,209a | -5,371a |
| General administration expenses | -2,574a | -2,453a |
| Other operating income | 1,779a | 1,897a |
| Other operating expenses | -5,039a | -8,867a |
| EBIT | -71a | 612a |
| Equity-method income (loss) | -132a | -162a |
| Financial income | 545a | 601a |
| Financial expenses | -2,676a | -2,672a |
| Financial result | -2,263a | -2,233a |
| Income before income taxes | -2,334a | -1,621a |
| Income taxes | -212a | -1,321a |
| Income after income taxes | -2,546a | -2,942a |
| Of which attributable to noncontrolling interest | 6a | -1a |
| Of which attributable to Bayer AG stockholders (net income) | -2,552a | -2,941a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Bayer’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.